clinically node-negative
Prediction of high nodal burden with ultrasound and magnetic resonance imaging in clinically node-negative breast cancer patients
... Since the publication of ACOSOG Z1011 trial, the role of axillary imaging has been redirected for predicting high nodal burden (≥ 3 metastatic ALNs) rather than predicting the presence of nodal metastases. Predicting ...
9
Total thyroidectomy without prophylactic central neck dissection in clinically node negative papillary thyroid cancer: is it an adequate treatment?
... Conclusions: The role of prophylactic central lymph node dissection in the management of papillary thyroid cancer remains controversial. Total thyroidectomy appears to be an adequate treatment for ...
8
Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node negative papillary thyroid cancer patients
... lymph node involvement of central and lateral levels is very com- mon in PTC, and micrometastases are observed in up to 80 % of cases, especially in young patients ...with node involvement, representing the ...
5
Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a
... CT is relatively low to detect suspicious LN in the cen- tral compartment [26]. Some authors have suggested that intraoperative frozen section examination of the ip- silateral central LN should be the primary surgical ...
9
<p>Sentinel Lymph Node Biopsy Was Associated With Favorable Survival Outcomes For Patients With Clinically Node-Negative Asian Melanoma</p>
... This retrospective study compared 127 patients receiving successful SLNB to 51 patients having only nodal observa- tion after primary surgery in a single institute in Taiwan. In the current study, SLNB followed by ...
10
Ultrasound-guided fine needle aspiration cytology in staging clinically node-negative invasive breast cancer
... were punctured and aspirated for cytological pretreatment examination. Forty-six patients of this group had sono- graphic suspicious nodes. Thirty-one out of these 46 nodes were positive. By puncturing normal nodes as ...
7
Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer
... lymph node dis- section (PALND), dissection of lymph nodes inferior to the ICBNs traced by dye, was a good supplementary pro- cedure to follow ...with clinically node-negative breast cancer ...
11
Results of a randomized controlled trial of level IIb preserving neck dissection in clinically node negative squamous carcinoma of the oral cavity
... with clinically and radiologically negative neck were randomized to IIb preserving superselective neck dissection or con- ventional supraomohyoid neck ...
8
Benefit of adjuvant chemotherapy based on lymph node involvement for oesophageal cancer following trimodality therapy
... were node-positive at the time of diagnosis and following surgery (cN+/pN+) had a smaller, yet still significant, improvement in survival with the addition of AC (median OS 27 vs 22 months; ...were ...
7
Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer
... lymph node metastasis, two recent studies have been ...lymph node involvement after analyzing the 70 NSCLC patients ...lymph node metastasis in clinically node-negative squamous ...
8
Prognostic Factors in Node Negative Penile Cancer.
... all node negative patients ...become clinically palpable has the same outcome as in patients who are clinically node negative and are offered prophylactic ...
60
Merrill_AY_Outcomes_After_Mastectomy_And_Lumpectomy_In_Octogenarians_and_Nonagenarians_With_Early_Stage_Breast_Cancer.pdf
... lymph node status should be routinely assessed for elderly patients with early- stage breast cancer has been debated in the ...with clinically node-negative breast cancer to surgery with ...
19
Five-year follow-up of treatment outcomes in patients with early-stage breast cancer and clinically negative axillary nodes treated with no lymph node dissection or axillary clearance
... with clinically node- negative breast cancer treated with total mastectomy alone, in whom the incidence of nodal metastases had been estimated to be 30% based on the pathology results of patients who ...
5
Neck dissection in node negative oral malignancies: is it justified
... detected node was round then malignant and benign if ...malignant node. If hilum is eccentric (distorted) or absent node was considered malignant and if it is central and well maintained then ...this ...
5
Nuclear localization and intensity of staining of nm23 protein is useful marker for breast cancer progression
... In conclusion nm23 protein expression appears expressed widely in normal breast, early and advanced stages of breast cancer, predominantly in ductal carcinoma. It sug- gests a less significance of nm23 induced pathway of ...
6
THE CUTANEOUS REACTION TO EGGWHITE
... negative skin tests in clinically sensitive in-. dividuals would also decrease[r] ...
9
The use of ultrasound in the clinical re-staging of the axilla after neoadjuvant chemotherapy (NACT).
... false negative rate include use of dual localisation (radioisotope and blue dye) and removal of at least 3 lymph nodes, but the logical step would be to ensure removal of the node, which was originally ...
13
Feasibility of sentinel lymph node biopsy in breast cancer patients clinically suspected of axillary lymph node metastasis on preoperative imaging
... The NCCN guideline recommends that SLNB should be performed in patients with clinically negative axillary LNs [10]. Still, many authorities consider clinically positive axillary LNs a ...
8
Selective Neck Dissection for Clinically Node Positive Oral Cavity Squamous Cell Carcinoma
... as clinically N+, with the clinical N+ neck defined as cervical lymph nodes detected at the physi- cal examination, imaging studies (either a computed to- mography scan, magnetic resonance imaging or positron ...
6
A clinically relevant gene signature in triple negative and basal like breast cancer
... discovery cohort (HR 0.38, 95% CI 0.22 to 0.67, P = 0.001) and in the second, larger validation cohort-C, (HR 0.21, 95% CI 0.07 to 0.62, P = 0.005). The only other variable with borderline statistical significance (HR ...
12